Finance
VistaGen Therapeutics Inc (NASDAQ: VTGN): Overvalued Compared To Others?
VistaGen Therapeutics Inc (NASDAQ:VTGN) price on Thursday, March 28, rose 15.54% above its previous day’s close as an upside momentum from buyers pushed the stock’s